Starcevic Manning Marta, Kroenke Mark A, Lee Stephanie A, Harrison Simon E, Hoofring Sarah A, Mytych Daniel T, Jawa Vibha
Pharmacokinetics & Drug Metabolism, Amgen, Thousand Oaks, CA 91320, USA.
One Amgen Center Drive, Mail Stop 30E-3-B, Thousand Oaks, CA 91320, USA.
Bioanalysis. 2017 Dec;9(23):1849-1858. doi: 10.4155/bio-2017-0185. Epub 2017 Oct 12.
Titer methods are commonly used to characterize the magnitude of an antidrug antibody response. Assay S/N is an appealing alternative, but the circumstances under which use of signal-to-noise (S/N) is appropriate have not been well defined.
We validated both titer and S/N-based methods for several therapeutics. S/N correlated strongly with titer both in aggregate and when examined on a per subject basis. Analysis of impact of antibody magnitude on pharmacokinetics yielded the same result using either method. Each assay demonstrated excellent precision, good linearity, and adequate drug tolerance.
Under these circumstances, assay S/N is a valid alternative to titer for assessment of the magnitude of an antidrug antibody response.
效价测定方法通常用于表征抗药物抗体反应的强度。分析信噪比(S/N)是一种有吸引力的替代方法,但使用信噪比(S/N)的合适情况尚未明确界定。
我们验证了几种治疗药物的效价测定和基于S/N的方法。总体上以及在个体水平上检查时,S/N与效价都有很强的相关性。使用这两种方法中的任何一种分析抗体强度对药代动力学的影响都得到了相同的结果。每种分析方法都显示出出色的精密度、良好的线性和足够的药物耐受性。
在这些情况下,分析S/N可作为效价测定的有效替代方法,用于评估抗药物抗体反应的强度。